Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
DOUTOR NICHIRES, 12% Increase in Ordinary Profit, Record High for The First Time in Nine Years, Increased Previous Year's Dividend by 2 yen, This Fiscal Year to Increase Dividend by 4 yen
3087 DOUTOR NICHIRES Holdings.,Co Ltd. 【J-GAAP】
Earnings ReportDOUTOR NICHIRES Holdings.,Co Ltd. <3087> [TSE Prime] announced its financial results after the market closed on April 14th (15:30). The consolidated ordinary profit for the fiscal year ending February 2025 increased 24.9% from the previous period to 9.61 billion yen. In the fiscal year ending February 2026, the profit is expected to grow by 11.5% to 10.7 billion yenExpected to reach record high profits for the first time in nine years. This will be the fifth consecutive term of revenue and the third consecutive term of profit growth.
At the same time, the company increased the annual dividend for the previous term from 48 yen to 50 yen (compared to 40 yen in the prior term), and has decided to increase the dividend this fiscal year to 54 yen, an increase of 4 yen from the previous fiscal year.
In the most recent three-month period, from December to February (4Q), the consolidated ordinary profit decreased to 1.56 billion yen, a 4.2% decrease compared to the same period last year. The operating profit margin remained almost flat, changing from 4.5% in the same period last year to 4.4%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Feb, 2023 | 126,864 | 2,969 | 3,466 | 3,429 | 77.6 | 30 | Apr 14, 2023 | J-GAAP |
Feb, 2024 | 140,625 | 7,322 | 7,701 | 5,491 | 124.9 | 40 | Apr 12, 2024 | J-GAAP |
Feb, 2025 | 148,822 | 9,597 | 9,615 | 6,880 | 157.0 | 50 | Apr 14, 2025 | J-GAAP |
YoY | +5.8% | +31.1% | +24.9% | +25.3% | +25.7% |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Feb, 2025 Guidance | 146,484 | 9,679 | 9,848 | 6,646 | 151.6 | 48 | Jan 14, 2025 | J-GAAP |
Feb, 2025 Results | 148,822 | 9,597 | 9,615 | 6,880 | 157.0 | 50 | Apr 14, 2025 | J-GAAP |
Revision Rate | +1.6% | -0.8% | -2.4% | +3.5% | +3.6% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar - Aug, 2024 | 75,263 | 5,728 | 5,732 | 4,217 | 96.2 | 23 | Oct 15, 2024 | J-GAAP |
Mar - Aug, 2025 Guidance | 78,237 | 5,959 | 6,019 | 4,093 | 97.4 | 27 | Apr 14, 2025 | J-GAAP |
YoY | +4.0% | +4.0% | +5.0% | -2.9% | +1.2% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Feb, 2024 | 140,625 | 7,322 | 7,701 | 5,491 | 124.9 | 40 | Apr 12, 2024 | J-GAAP |
Feb, 2025 | 148,822 | 9,597 | 9,615 | 6,880 | 157.0 | 50 | Apr 14, 2025 | J-GAAP |
Feb, 2026 Guidance | 154,514 | 10,599 | 10,723 | 7,156 | 170.3 | 54 | Apr 14, 2025 | J-GAAP |
YoY | +3.8% | +10.4% | +11.5% | +4.0% | +8.5% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec - Feb, 2023 | 34,391 | 1,560 | 1,638 | 519 | 11.8 | 4.5 | Apr 12, 2024 | J-GAAP |
Mar - May, 2024 | 36,906 | 2,981 | 3,100 | 2,379 | 54.3 | 8.1 | Jul 12, 2024 | J-GAAP |
Jun - Aug, 2024 | 38,357 | 2,747 | 2,632 | 1,838 | 41.9 | 7.2 | Oct 15, 2024 | J-GAAP |
Sep - Nov, 2024 | 37,168 | 2,259 | 2,314 | 1,569 | 35.8 | 6.1 | Jan 14, 2025 | J-GAAP |
Dec - Feb, 2024 | 36,391 | 1,610 | 1,569 | 1,094 | 25.0 | 4.4 | Apr 14, 2025 | J-GAAP |
YoY | +5.8% | +3.2% | -4.2% | +110.8% | +111.5% |
Related Articles
TOHO, 15% Decrease in Ordinary Profit for The Current Fiscal Year
GDEP ADVANCE, The Current Fiscal Year Ordinary Profit Revised Upward by 16%, Raises Record High Profit Forecast, Dividend Revised Upward by 5.5 yen
NISSO PRONITY, First Half Ordinary Profit Increases by 4%, Current Fiscal Year Dividend Revised Upward by 10 yen
Lacto Japan, Dec-Feb (1Q) Ordinary Profit Increases by 43%
SMN, Last Fiscal Year Net Income Revised Upward by 93%
DEMAE-CAN, First Half Ordinary Profit Loss Narrows, Dec-Feb Ordinary Profit Loss Narrows
Copa Corp, Net Income/Loss Unexpectedly Turn to Loss for Last Fiscal Year, The Current Fiscal Year's Net Income to Narrow
STUDIO ALICE, 6% Decrease in Ordinary Profit for The Current Fiscal Year
COSMOS Pharma, Jun-Feb (Cumulative 3Q) Ordinary Profit Increases by 30%, Dec-Feb Ordinary Profit Increases by 40%
FP Partner, Dec-Feb (1Q) Ordinary Profit Decreases by 42%